Clicky

Cannabis

Best Kratom Supplements? FDA Status, Label Checks and Safety Checklist

Kratom isn't FDA approved, and the FDA says it isn't lawfully marketed as a dietary supplement, so here's how to judge labels, lab reports, forms and safety before you buy.

Short answer: no kratom product can be named the best by a ranking you can check, and the FDA says kratom is not lawfully marketed in the U.S. as a drug product, a dietary supplement, or a food additive in conventional food. Kratom is not FDA approved for any use. What you can check for yourself is the label, a lab report matched to the lot you’re buying, the ingredient list, the warnings, the age limit, and the seller’s written return terms.

Best Kratom Supplements?: Safety, Label, Checklist

Is kratom legal to sell in the U.S.?

Kratom is a tropical tree, Mitragyna speciosa, native to Southeast Asia. The FDA says there are no prescription or over-the-counter drug products containing kratom or its known alkaloids legally on the market in the U.S. On the supplement question, the FDA has concluded there is inadequate information to give reasonable assurance that kratom as a dietary ingredient does not present a significant or unreasonable risk of illness or injury, so dietary supplements that are or contain kratom are adulterated under federal law.

That’s why many sellers still call their kratom a supplement while the FDA says it isn’t lawfully marketed that way. The National Center for Complementary and Integrative Health (NCCIH) adds that kratom wasn’t marketed as a dietary ingredient in the U.S. before October 15, 1994, so evidence of safety is required for it.

The DEA’s kratom chemistry summary says kratom itself remains an unscheduled botanical and is not a controlled substance under the Controlled Substances Act.

State and local rules differ. Cleveland Clinic, citing the Legislative Analysis and Public Policy Association as of August 2026, reports that 10 states ban kratom and roughly two dozen others regulate it in some form. Some cities and counties have their own bans, so check your own state and local rules directly.

What makes a kratom product the best one?

The Research Team doesn’t rank kratom by strength, potency, or the effect it’s said to give. The DEA’s chemistry summary says kratom’s alkaloid content varies significantly with plant strain and maturity, so a strength claim is hard for a buyer to check. What you can check is this:

  • The ingredient list. It should say whether the product is leaf, an extract, or something with added 7-OH. These are different product types, and this guide treats them separately.
  • A lab report for your lot. The lot number on the report should match the lot number on your package. A report only speaks for the batch it tested.
  • The warnings. FDA lists liver toxicity, seizures, and substance use disorder as serious risks of kratom use.
  • The age limit, stated on the label or the product page.
  • The return terms, in writing, read before you order.
  • The claims. The FDA has not approved kratom for pain relief, anxiety, depression, or opioid withdrawal, so a label that promises any of those is making a claim the FDA says has no approved basis.

A brand name on its own tells you very little about what’s in the bag. Judge the label and the lot report instead.

Which kratom is the strongest?

The Research Team doesn’t name a strongest kratom or a strongest brand. Strength depends on the alkaloid content of the specific lot, which is the thing the label and lot report should be checked against. For the side-effect questions that come up with branded kratom, see our super speciosa side effects guide.

Is kratom powder or pills better?

Neither form is ranked here. Leaf powder, capsules, and tea are all leaf-based in the sources, and what matters for buying is what the label tells you. The forms below are the ones the sources describe.

Form What the sources say it is What to check on the label
Dried leaf powder Leaves are dried and used to make tea or put into capsules, according to WebMD. The powder can also be mixed with water to make a drink. Says leaf, names Mitragyna speciosa, shows a lot number, and points to a lab report for that lot.
Capsules An encapsulated powder, per the DEA. WebMD says the capsule has crushed kratom leaves in it. Says whether the contents are leaf or extract, shows a lot number, and lists the warnings.
Tea Brewed from the leaves, per WebMD. Says leaf, lists the warnings, and gives the age limit.
Whole or crushed leaves Sold online, per the DEA. WebMD notes that leaves can also be chewed or smoked. Says leaf, shows a lot number, and lists the warnings.
Extract or resin The DEA describes extract resin “pies,” 40-gram pellets made from reduced extract. See the extract section below. The maker’s stated ratio, a lab report for that lot, and the warnings.
Tablets, chewables, shots The FDA and DEA describe these forms for 7-OH products. See the 7-OH section below. Not covered as a leaf product.

Are kratom extracts a better buy?

Extracts are a separate product class. A 2026 study in the Journal of Analytical Toxicology, which gave people single and then 15 daily doses of a concentrated kratom extract containing 39.5% mitragynine, found that concentrated extracts may yield greater overall mitragynine exposure than dried leaf powder or kratom tea at comparable doses. The study also found the 7-OH to mitragynine ratio shifted after repeated dosing. The extract pharmacokinetics study lists its conflict of interest as follows: all authors are consultants to NP Pharma, LLC and were compensated for writing the manuscript. A percentage on an extract label is the maker’s figure, not a test of that lot’s composition, which is why the lab report matters more here.

What is 7-OH, and is it stronger than kratom?

On the receptor measure the FDA cites, yes. The FDA says 7-hydroxymitragynine (7-OH) is a minor alkaloid, under 2% of total alkaloid content in natural kratom leaves, but it shows substantially greater mu-opioid receptor potency than mitragynine, kratom’s main alkaloid, and than morphine. That’s a laboratory comparison at one receptor, not a measure of what a person would feel.

The FDA says 7-OH is not an approved drug, that no food additive regulation has authorized its use in food, and it has warned consumers against using products labeled as 7-hydroxymitragynine. The Research Team doesn’t recommend or link to concentrated 7-OH products.

On October 14, 2026, the DEA published a Federal Register notice that is a proposed amendment and notice of intent about 7-OH and a related compound, mitragynine pseudoindoxyl. It is a notice of intent, and it is not a finished federal action on 7-OH.

What does 1 gram of kratom feel like?

The Research Team doesn’t translate a weight into a feeling. The FDA says how much is taken and under what conditions determines whether kratom causes harm, and the DEA’s chemistry summary notes that alkaloid content varies between products.

What the research describes is a pattern. The DEA says low doses of kratom produce stimulant effects such as alertness and physical energy, while high doses produce sedation and euphoria, and that effects start within 5 to 10 minutes and last 2 to 5 hours. In the single-dose trial in healthy volunteers described below, subjective effects were modest and rose with dose, and the highest single dose was the only one with a statistically significant rise over placebo.

Is kratom an opioid or opiate?

Kratom is opioid-like, not a prescription opioid. Its two best-studied compounds, mitragynine and 7-OH, bind to the same mu opioid receptors in the brain as opioid drugs such as codeine, according to the FDA’s kratom page. WebMD notes that experts consider kratom an opioid-like substance for this reason, and it can be habit-forming in the way opioids can.

Is it okay to take kratom every day?

No long-term study answers this. NCCIH says the long-term effects of kratom use are not well understood, and that regular users may experience withdrawal symptoms if they stop.

The closest evidence is the 2026 trial that gave healthy volunteers 15 daily doses over 47 days, described in the table below. It found no serious adverse events or deaths, and the authors concluded the powder was well tolerated at the dose ranges tested. Side effects rose with dose, and the most common ones after daily dosing were headache, feeling hot, an increased alanine aminotransferase level, and nausea. A 2024 expert review in Expert Review of Clinical Pharmacology wrote that escalating dose and increased use frequency raise the risk for toxic events, especially with polysubstance use or the development of a use disorder. If you’re thinking about daily use, a clinician is the right person to talk to about your own situation.

What counts as heavy kratom use?

No source gives a heavy-use amount. The clinical markers are the ones used for kratom use disorder. A 2024 review in Current Psychiatry Reports notes that people who meet DSM-5 criteria for kratom use disorder typically do so through tolerance and withdrawal, using more than intended, and craving. Those are the signs to watch for in yourself, and they’re worth raising with a clinician.

What are the side effects of kratom?

Cleveland Clinic lists the following effects, citing NIDA and other agencies.

Level Effects listed
Mild Constipation, drowsiness and sedation, dry mouth, frequent urination, hypothyroidism, itching, lower libido, nausea and vomiting, sweating, weight loss
More serious Addiction, anorexia, heart attack, abnormal heart rhythms, high blood pressure, delusion and hallucination, liver damage and liver failure, seizures
Newborns Neonatal opioid withdrawal syndrome has been documented in infants whose mothers regularly used kratom

NCCIH says fatal overdoses from kratom alone appear to be extremely rare, and that deaths linked to kratom have involved combinations with other drugs. The DEA cites FDA adverse event data showing 1,720 reports involving kratom from 2008 to 2026, of which 1,585 were serious and 765 involved death. Those are reports, not rates of harm among all users. The CDC’s poison-center report covers exposure reports from 53 poison centers from 2015 to 2025 and notes that the reports are voluntary and self-reported. If you have a bad reaction, the FDA asks you to report it through its MedWatch program or call 1-800-332-1088 for a form.

Who should avoid kratom?

The FDA warns consumers not to use kratom because of the risk of serious adverse events, including liver toxicity, seizures, and substance use disorder. Some groups need a clinician’s advice before any use.

  • Pregnancy or breastfeeding. Neonatal opioid withdrawal syndrome has been documented in infants whose mothers regularly used kratom. If you’re pregnant or breastfeeding, talk with a clinician before using kratom.
  • Prescription medicines. The CDC notes kratom use with alcohol, opioids, benzodiazepines, stimulants, and antidepressants might increase risk. Check with your pharmacist or clinician before combining it with any prescription.
  • Liver disease. The FDA lists liver toxicity among its serious concerns, so talk with a clinician first.
  • A history of substance use. The CDC cites previous studies finding that approximately one third of kratom users met criteria for another substance use disorder.

What can’t you mix kratom with?

The CDC says kratom use with alcohol, opioids, benzodiazepines, stimulants, and antidepressants might increase risk through additive effects on the central nervous system and through interactions that raise exposure to the other substance. WebMD says that caffeine, as a stimulant, can make kratom’s effects worse, and that sedating substances can intensify its sedation and even lead to breathing trouble.

A clinical study of 12 healthy adults given a single low dose of kratom tea found a modest increase in midazolam exposure, a drug processed by the CYP3A enzyme, and no change for dextromethorphan, which is processed by CYP2D6. The authors wrote that co-consuming kratom with certain drugs extensively metabolized by CYP3A may precipitate serious interactions. NCCIH says more research is needed on kratom’s drug interactions. Talk with your pharmacist or clinician before combining kratom with any medicine or supplement.

Will kratom show up on a drug test?

WebMD says kratom won’t show up on the standard 5-panel drug test, which checks for marijuana (THC), cocaine, amphetamines, opioids, and phencyclidine (PCP). That answer covers the standard panel only. If your test is a different panel, ask the lab or the person ordering the test what it includes.

What does the research on kratom cover?

The evidence is early. NCCIH says very little research in people has evaluated kratom’s health effects, and that kratom has not been shown to be safe and effective for this or any other medical use. Researchers are studying whether it helps with opioid withdrawal, but that question is open. For a wider overview, see our kratom benefits evidence (our research library) page. The studies below are the human trials most relevant to buying decisions.

Study Who was studied, and how What it found Limits the study states
2026 safety trial, Therapeutic Drug Monitoring 116 healthy volunteers (49 given dried leaf powder, 67 placebo), randomized, double-blind, placebo-controlled; single escalating doses, then 15 daily doses over 47 days. Nonsmoking adults aged 18 to 55 who had never used kratom or had not used it in 12 months or more. No serious adverse events or deaths. Side effects rose with dose. Most common after single doses: dizziness, nausea, feeling of relaxation. After daily doses: headache, feeling hot, increased alanine aminotransferase level, nausea. The authors describe the powder as well tolerated at the dose ranges tested.
2026 abuse-potential study, Drug Testing and Analysis 116 healthy kratom-naive adults (49 given leaf powder capsules, 67 placebo), single dose or 15 daily doses. Subjective effects were dose-related and modest. The only significant rise over placebo came at the highest single dose. Effects decreased with repeated dosing. No participant met the threshold for clinically meaningful opioid withdrawal. Side effects were generally mild. The authors stress the importance of dose control and product standardization and call for further research.
2026 pilot study, Journal of Clinical Psychopharmacology 40 recreational polydrug users who had experience with opioids, single doses in cohorts, with a placebo group. Most common side effects were somnolence, vomiting, and nausea. Pupil constriction occurred at doses of 3 g and above. The highest dose increased ratings of drug liking, good effects, and high. Kratom from a single source with trace 7-OH. The authors say the results may not represent other kratom-containing products.
2025 phase 1 study, Psychopharmacology 15 healthy volunteers in two parts, placebo-controlled, single-blind, single doses of isolated mitragynine. The lowest dose increased ratings of arousal and attention. The highest dose increased ratings of amnesia and mild psychopathological symptoms. Well tolerated up to the highest dose. Tests an isolated compound, not a leaf product, in a small group.
Drug interaction study 12 healthy adults given a single low dose of kratom tea, with midazolam and dextromethorphan as probe drugs. Midazolam exposure rose modestly; dextromethorphan was unchanged. The authors infer kratom mainly inhibited intestinal CYP3A. Twelve participants, one low dose of tea.
Extract pharmacokinetics study, Journal of Analytical Toxicology Humans given single escalating doses and 15 daily doses of a concentrated extract with 39.5% mitragynine. Concentrated extracts may yield greater mitragynine exposure than leaf powder or tea at comparable doses. All authors are consultants to NP Pharma, LLC and were compensated for writing the manuscript.

A 2020 review in The Primary Care Companion for CNS Disorders, titled Kratom (Mitragyna speciosa): Friend or Foe?, found that kratom use started as self-medication for an opioid use disorder or pain, in the absence of effective alternatives, is associated with a risk of kratom dependence, withdrawal, and life-threatening toxicity.

Do online kratom reviews tell you which one is best?

Reviews describe how one person felt. They don’t tell you what’s in a given lot, and they can’t replace the label or the lot’s lab report. The Research Team doesn’t rate sellers or treat star ratings as proof of quality.

Do brand names or extracts tell you which kratom is best?

No. The Research Team doesn’t name brands as winners, and a brand name doesn’t say what’s in the batch. If a seller offers an extract powder, check the lot’s lab report, the maker’s stated ratio, the warnings, and the return terms before deciding.

Before you order

  • Confirm the form and whether it’s leaf or extract. Leave concentrated 7-OH products out of the comparison.
  • Match the lot number on your package to the lot number on the lab report.
  • Read the warnings, the age limit, and the return terms in writing.
  • Check your state and local rules, which differ.
  • Talk with a clinician or pharmacist if you’re pregnant or breastfeeding, take prescription medicines, have liver disease, or have a history of substance use. For withdrawal questions, see our kratom withdrawal guide.

By HealthDataConsortium.org Research Team

This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.